Search Within

Robin Michele Trocola

Formats
  1. Meeting Abstract (3)
  2. Journal Article (1)
Groups
  1. Center for Pancreatic Cancer Research (4)
  2. Department of Medicine (4)
  3. Gastrointestinal Oncology Service (4)
  4. Solid Tumor Oncology Division (4)
  5. Nursing (3)
  6. Biostatistics Service (2)

More Groups

People
  1. David Kelsen (4)
  2. Manish Shah (4)
  3. David Ilson (3)
  4. Jennifer Russo (3)
  5. Lawrence Schwartz (2)
  6. Marinela Capanu (2)

More People

Years
  1. 2007 (3)
  2. 2006 (1)
Publications
  1. Journal of Clinical Oncology (4)
Publishers
  1. American Society of Clinical Oncology (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Volumetric 3D CT analysis - an early predictor of response to therapy
    Meeting Abstract

    Schwartz, L. H.; Curran, S.; Trocola, R.; Randazzo, J.; Ilson, D.; Kelsen, D.; Shah, M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A phase II study of preoperative chemotherapy with irinotecan (CPT) and cisplatin (CIS) for gastric cancer (NCI 5917): FDG-PET/CT predicts patient outcome
    Meeting Abstract

    Shah, M. A.; Yeung, H.; Coit, D.; Trocola, R.; Ilson, D.; Randazzo, J.; Tang, L.; Brennan, M.; Divgi, C.; Kelsen, D. P.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Incidence and significance of thromboembolic events (TE) in patients with gastrointestinal (GI) and non-GI malignancies on systemic cytotoxic therapy
    Meeting Abstract

    Asmis, T. R.; Templeton, M.; Trocola, R.; Pincus, N.; Randazzo, J.; Marinela, C.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinorna
    Journal Article

    Shah, M. A.; Ramanathan, R. K.; Ilson, D. H.; Levnor, A.; D'adamo, D.; O'reilly, E.; Tse, A.; Trocola, R.; Schwartz, L.; Capanu, M.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save